Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (501-510 of 514) with videos related to

Pageof 52
Sort By:
Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.
Breast (Edinburgh, Scotland)|April 16, 2025
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 studyMatheus de Oliveira Andrade, Isabella Gonçalves Gutierres, Monique Celeste Tavares, et al.
The Oncologist|June 28, 2017
Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind TrialDaniel Ciampi de Andrade, Manoel Jacobsen Teixeira, Ricardo Galhardoni, et al.
Breast Cancer Research and Treatment|March 18, 2026
Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: real-world data from the Neo-Real/GBECAM 0123 studyMatheus de Oliveira Andrade, Renata Colombo Bonadio, Agustina Ipiña, et al.
NPJ Breast Cancer|March 2, 2026
Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123Mariana Carvalho Gouveia, Romualdo Barroso-Sousa, Laura Lapuchesky, et al.
NPJ Breast Cancer|June 2, 2026
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohortMonique Celeste Tavares, Flávia C Balint, Romualdo Barroso-Sousa, et al.
Ecancermedicalscience|February 15, 2017
Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour groupRachel P Riechelmann, Rui F Weschenfelder, Frederico P Costa, et al.
Physical Review Letters|April 29, 2024
Proton Shell Gaps in N=28 Nuclei from the First Complete Spectroscopy Study with FRIB Decay Station InitiatorI Cox, Z Y Xu, R Grzywacz, et al.
Ecancermedicalscience|April 23, 2021
Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancerDuilio R Rocha-Filho, Renata D'Alpino Peixoto, Rui F Weschenfelder, et al.
Ecancermedicalscience|November 19, 2020
Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancerRenata D'Alpino Peixoto, Duilio R Rocha-Filho, Rui F Weschenfelder, et al.
Pageof 52

Showing results (501-510 of 514) with videos related to

Sort By:
Pageof 52
Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.
Breast (Edinburgh, Scotland)|April 16, 2025
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 studyMatheus de Oliveira Andrade, Isabella Gonçalves Gutierres, Monique Celeste Tavares, et al.
The Oncologist|June 28, 2017
Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind TrialDaniel Ciampi de Andrade, Manoel Jacobsen Teixeira, Ricardo Galhardoni, et al.
Breast Cancer Research and Treatment|March 18, 2026
Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: real-world data from the Neo-Real/GBECAM 0123 studyMatheus de Oliveira Andrade, Renata Colombo Bonadio, Agustina Ipiña, et al.
NPJ Breast Cancer|March 2, 2026
Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123Mariana Carvalho Gouveia, Romualdo Barroso-Sousa, Laura Lapuchesky, et al.
NPJ Breast Cancer|June 2, 2026
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohortMonique Celeste Tavares, Flávia C Balint, Romualdo Barroso-Sousa, et al.
Ecancermedicalscience|February 15, 2017
Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour groupRachel P Riechelmann, Rui F Weschenfelder, Frederico P Costa, et al.
Physical Review Letters|April 29, 2024
Proton Shell Gaps in N=28 Nuclei from the First Complete Spectroscopy Study with FRIB Decay Station InitiatorI Cox, Z Y Xu, R Grzywacz, et al.
Ecancermedicalscience|April 23, 2021
Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancerDuilio R Rocha-Filho, Renata D'Alpino Peixoto, Rui F Weschenfelder, et al.
Ecancermedicalscience|November 19, 2020
Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancerRenata D'Alpino Peixoto, Duilio R Rocha-Filho, Rui F Weschenfelder, et al.
Pageof 52